Argent Biopharma (AU:RGT) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Argent Biopharma Limited has announced the issuance of 4 million new fully paid ordinary shares following approval at the company’s general meeting on October 1, 2024. These shares are now set to be quoted on the ASX under the ticker code RGT, as of October 15, 2024. This move marks a newsworthy development for investors tracking the biopharmaceutical sector.
For further insights into AU:RGT stock, check out TipRanks’ Stock Analysis page.